MENU
+Compare
SVRA
Stock ticker: NASDAQ
AS OF
May 14, 04:59 PM (EDT)
Price
$2.99
Change
+$0.02 (+0.67%)
Capitalization
512.72M

SVRA Savara Forecast, Technical & Fundamental Analysis

Savara Inc is a biopharmaceutical company... Show more

Industry: #Biotechnology
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SVRA with price predictions
May 13, 2025

SVRA's Stochastic Oscillator dives oversold zone

The Stochastic Oscillator for SVRA moved into oversold territory on May 13, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

SVRA moved above its 50-day moving average on May 12, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SVRA advanced for three days, in of 238 cases, the price rose further within the following month. The odds of a continued upward trend are .

SVRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 155 cases where SVRA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SVRA moved out of overbought territory on May 05, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on May 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SVRA as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SVRA turned negative on May 06, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SVRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SVRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.990) is normal, around the industry mean (14.386). P/E Ratio (0.000) is within average values for comparable stocks, (64.760). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.146). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (254.479).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SVRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SVRA is expected to report earnings to fall 11.67% to -10 cents per share on August 07

Savara SVRA Stock Earnings Reports
Q2'25
Est.
$-0.11
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.02
Q3'24
Est.
$-0.11
Q2'24
Missed
by $0.02
The last earnings report on May 13 showed earnings per share of -11 cents, missing the estimate of -10 cents. With 399.10K shares outstanding, the current market capitalization sits at 512.72M.
A.I. Advisor
published General Information

General Information

a pharmaceuticals developer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1717 Langhorne Newtown Road
Phone
+1 512 614-1848
Employees
37
Web
https://www.savarapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA334.0715.69
+4.93%
Tesla
BTC.X104169.8100001356.851600
+1.32%
Bitcoin cryptocurrency
GME28.390.34
+1.21%
GameStop Corp
AAPL212.932.14
+1.02%
Apple
SPY586.843.85
+0.66%
SPDR® S&P 500® ETF

SVRA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with LRMR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then LRMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
-1.66%
LRMR - SVRA
48%
Loosely correlated
-9.86%
ATXS - SVRA
43%
Loosely correlated
-10.76%
CCCC - SVRA
43%
Loosely correlated
-5.06%
KYMR - SVRA
43%
Loosely correlated
-3.20%
CRNX - SVRA
43%
Loosely correlated
-7.11%
More